A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...

Eli Lilly has escalated its legal offensive against compounding pharmacies accused of selling unauthorized copies of its blockbuster diabetes and weight-loss drugs containing tirzepatide, the active ...

You can reach Katie on Signal at palmer.01. Amid ongoing battles over alternate supplies of blockbuster weight loss drugs, Eli Lilly filed new lawsuits against four telehealth firms and their ...

Amid ongoing battles over alternate supplies of blockbuster weight loss drugs, Eli Lilly filed new lawsuits against four telehealth firms and their affiliates, but is using a new line of attack ...

Following a similar decision in case the trade group Outsourcing Facilities Association brought against FDA over its decision ...

Merck Animal Health is investing $895 million in its Kansas facility. Novo Nordisk anticipates Wegovy sales recovery ...

Branded drug manufacturers, including Eli Lilly and Company (Eli Lilly), have been pursuing various legal actions against compounding pharmacies ...

COMPOUNDING PHARMACY: A look at the safety and affordability of Big Pharma's new rival Eli Lilly’s lawsuit sets up a battle over access to a multi-billion dollar market, fueled by the demand ...

Following the company’s announcement that its diabetes and weight-loss drug helped patients lose up to 16 pounds over 40 weeks, Eli Lilly’s (LLY) stock shot up on Thursday. The announcement confirms ...

Eli Lilly, for its part, sells tirzepatide as Mounjaro and Zepbound for diabetes and obesity, respectively. In addition, retatrutide is Lilly’s next-generation weight loss candidate.

Eli Lilly's legal actions against Empower and other compounding pharmacies come several months after the FDA announced that a shortage of Mounjaro and Zepbound had been resolved. Mounjaro and ...

Eli Lilly has unleashed another wave of litigation against four telehealth brands in its widening legal war with sellers of alternative versions of its popular diabetes and weight-loss drugs.